Genetic/familial high-risk assessment : Breast, ovarian, and pancreatic (version 1, 2021). National Comprehensive Cancer Network. URL: https://www.nccn.org/professionals/physician_gls/pdf/genetics_screening.pdf [Accessed 10 12 2021  ]

Genetic/familial high-risk assessment : Colorectal (version 1, 2021). National Comprehensive Cancer Network. URL: https://www.nccn.org/professionals/physician_gls/pdf/genetics_colon.pdf [Accessed 10 12 2021  ]

Prostate cancer early detection (2021) National Comprehensive Cancer Network. URL: https://www.nccn.org/professionals/physician_gls/pdf/prostate_detection.pdf [Accessed 10 12 2021  ]

Childers CP, Childers KK, Maggard-Gibbons M, Macinko J (2017) National estimates of genetic testing in Women with a history of breast or ovarian Cancer. J Clin Oncol 35(34):3800–3806

Article  PubMed  PubMed Central  Google Scholar 

Hughes KS (2017) Genetic testing: what problem are we trying to solve. J Clin Oncol 35(34):3789–3791

Article  PubMed  Google Scholar 

Rao SK, Thomas KA, Singh R, Biltibo E, Lammers PE, Wiesner GL (2021) Increased ease of access to genetic counseling for low-income women with breast cancer using a point of care screening tool. J Community Genet 12(1):129–136

Article  PubMed  PubMed Central  Google Scholar 

Knapke S, Haidle JL, Nagy R, Pirzadeh-Miller S (2016) The current state of cancer genetic counseling access and availability. Genet Med 18(4):410–412

Article  CAS  PubMed  Google Scholar 

Whitworth P, Beitsch P, Arnell C et al (2017) Impact of payer constraints on access to genetic testing. J Oncol Pract 13(1):e47–e56

Article  PubMed  Google Scholar 

Muessig KR, Zepp JM, Keast E et al (2022) Retrospective assessment of barriers and access to genetic services for hereditary cancer syndromes in an integrated health care delivery system. Hered Cancer Clin Pract 20(1):7

Article  PubMed  PubMed Central  Google Scholar 

Delikurt T, Williamson GR, Anastasiadou V, Skirton H (2015) A systematic review of factors that act as barriers to patient referral to genetic services. Eur J Hum Genet 23(6):739–745

Article  PubMed  Google Scholar 

Beard C, Monohan K, Cicciarelli L, James PA (2021) Mainstream genetic testing for breast cancer patients: early experiences from the Parkville Familial Cancer Centre. Eur J Hum Genet 29(5):872–880

Article  PubMed  PubMed Central  Google Scholar 

George A, Riddell D, Seal S et al (2016) Implementing rapid, robust, cost-effective, patient-centred, routine genetic testing in ovarian cancer patients. Sci Rep 6:29506

Article  PubMed  PubMed Central  Google Scholar 

Ogrinc G, Davies L, Goodman D, Batalden P, Davidoff F, Stevens D (2016) SQUIRE 2.0 (Standards for QUality Improvement Reporting Excellence): revised publication guidelines from a detailed consensus process. BMJ Qual Saf 25(12):986–992

Article  PubMed  Google Scholar 

Manahan ER, Kuerer HM, Sebastian M et al (2019) Consensus guidelines on genetic testing for hereditary breast cancer from the American society of breast surgeons. Ann Surg Oncol 26(10):3025–3031

Article  PubMed  PubMed Central  Google Scholar 

Grindedal EM, Jørgensen K, Olsson P et al (2020) Mainstreamed genetic testing of breast cancer patients in two hospitals in South Eastern Norway. Fam Cancer 19(2):133–142

Article  CAS  PubMed  PubMed Central  Google Scholar 

Mahmoodi N, Sargeant S (2019) Shared decision-making - rhetoric and reality: Women’s experiences and perceptions of adjuvant treatment decision-making for breast cancer. J Health Psychol 24(8):1082–1092

Article  PubMed  Google Scholar 

Tung NM, Boughey JC, Pierce LJ et al (2020) Management of hereditary breast cancer: American society of clinical oncology, American society for radiation oncology, and society of surgical oncology guideline. J Clin Oncol 38(18):2080–2106

Article  CAS  PubMed  Google Scholar 

Tutt ANJ, Garber JE, Kaufman B et al (2021) Adjuvant olaparib for patients with BRCA1- or BRCA2-Mutated breast Cancer. N Engl J Med 384(25):2394–2405

Article  CAS  PubMed  PubMed Central  Google Scholar 

Robson M, Im SA, Senkus E et al (2017) Olaparib for metastatic breast cancer in patients with a germline BRCA mutation. N Engl J Med 377(6):523–533

Article  CAS  PubMed  Google Scholar 

King MC, Levy-Lahad E, Lahad A (2014) Population-based screening for BRCA1 and BRCA2: 2014 Lasker Award. JAMA 312(11):1091–1092

Article  CAS  PubMed  Google Scholar 

Hughes KS, Yin K (2022) A woman needs to know she is a BRCA carrier before she develops breast Cancer. Ann Surg Oncol 29(8):4667–4669

Article  PubMed  Google Scholar 

Charron M, Kaiser B, Dauge A et al (2022) Integrating hereditary breast and ovarian cancer genetic counselling and testing into mainstream clinical practice: legal and ethical challenges. Crit Rev Oncol Hematol 178:103797

Article  PubMed  Google Scholar 

Swisher EM, Rayes N, Bowen D et al (2020) Results from MAGENTA: a national randomized four-arm noninferiority trial evaluating pre- and post-test genetic counseling during online testing for breast and ovarian cancer genetic risk. J Clin Oncol 38(15 suppl):1506

Article  Google Scholar 

Pal T, Shah P, Weidner A et al (2023) Inherited Cancer knowledge among black females with breast Cancer before and after viewing a web-based Educational Video. Genet Test Mol Biomarkers 27(1):1–4

Article  PubMed  Google Scholar 

Aeilts AM, Carpenter KM, Hovick SR, Byrne L, Shoben AB, Senter L (2021) The impact of a cascade testing video on recipients’ knowledge, cognitive message processing, and affective reactions: a formative evaluation. J Genet Couns 30(3):656–664

Article  CAS  PubMed  Google Scholar 

Meiser B, Woodward P, Gleeson M et al (2022) Pilot study of an online training program to increase genetic literacy and communication skills in oncology healthcare professionals discussing BRCA1/2 genetic testing with breast and ovarian cancer patients. Fam Cancer 21(2):157–166

Article  PubMed  Google Scholar 

Lapointe J, Dorval M, Chiquette J et al (2021) A collaborative model to implement flexible, accessible and efficient Oncogenetic Services for Hereditary breast and ovarian Cancer: the C-MOnGene study. Cancers (Basel) 13(11):2729

Article  CAS  PubMed  Google Scholar 

Nilsson MP, Nilsson ED, Borg Ã, Brandberg Y, Silfverberg B, Loman N (2019) High patient satisfaction with a simplified BRCA1/2 testing procedure: long-term results of a prospective study. Breast Cancer Res Treat 173(2):313–318

Article  CAS  PubMed  Google Scholar 

Bokkers K, Bleiker EMA, Hoogendam JP et al (2022) Mainstream genetic testing for women with ovarian cancer provides a solid basis for patients to make a well-informed decision about genetic testing. Hered Cancer Clin Pract 20(1):33

Article  PubMed  PubMed Central  Google Scholar